SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-762396
Filing Date
2016-11-08
Accepted
2016-11-08 07:49:39
Documents
49
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d268674d10q.htm 10-Q 245033
2 EX-31.1 d268674dex311.htm EX-31.1 9018
3 EX-31.2 d268674dex312.htm EX-31.2 9019
4 EX-32.1 d268674dex321.htm EX-32.1 4360
5 EX-32.2 d268674dex322.htm EX-32.2 4361
  Complete submission text file 0001193125-16-762396.txt   2055921

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT galt-20160930.xml EX-101.INS 253798
7 XBRL TAXONOMY EXTENSION SCHEMA galt-20160930.xsd EX-101.SCH 32194
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20160930_cal.xml EX-101.CAL 32359
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20160930_def.xml EX-101.DEF 184617
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20160930_lab.xml EX-101.LAB 250686
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20160930_pre.xml EX-101.PRE 219410
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31791 | Film No.: 161979985
SIC: 2834 Pharmaceutical Preparations